HomeAI · summaries
Storia in 8 fonti
Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India
India's drug regulator has approved Takeda's Qdenga dengue vaccine, the first of its kind. This vaccine is expected to become available in India during the first half of 2027. Qdenga offers protection against all four dengue virus serotypes for individuals aged four to sixty. The vaccine demonstrated significant efficacy in late-stage trials, reducing cases and hospitalisations. Takeda is also partnering with Biological E to boost global manufacturing capacity for Qdenga.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGA
Takeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individuals aged four to sixty years old. QDENGA…
- ·
hindustantimes.com
India gets first dengue vaccine as DCGI approves Takeda’s QDENGA
QDENGA can be administered to individuals irrespective of previous dengue exposure, without requiring pre-vaccination testing.
